Background {#Sec1}
==========

Urinary stone is one of the most prevalent urological disorders. Reports suggest that up to 12% of people will suffer from urinary tract calculi during their lifetime, and the rates of recurrence is close to 50% \[[@CR1]\]. There are several treatment modalities for renal stones, including observation expecting spontaneous passage, extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL), and retrograde intrarenal surgery (RIRS) using flexible ureterorenoscope \[[@CR2]\]. PCNL is currently the standard treatment for large renal stones considered too large for or refractory to shock wave lithotripsy \[[@CR3], [@CR4]\]. Conventionally, a 20-24 French nephrostomy catheter is placed routinely after PCNL to provide urine drainage, prevent extravasation of urine, and make tamponade against bleeding \[[@CR5], [@CR6]\]. In addition, it can be used as a tract for a second-look PCNL \[[@CR7]\]. The need for placing a conventional large-bore nephrostomy catheter has been questioned because of its accompanying increase in postoperative discomfort and other morbidity, and the low incidence of second-look operations \[[@CR8], [@CR9]\]. In recent years, tubeless or small-bore PCNL has been widely used, and previously reported systematic reviews have demonstrated the safety and efficacy in these techniques.

The recently introduced network meta-analysis is a meta-analysis in which multiple treatments are compared using both direct comparisons of interventions within randomized controlled trials (RCTs), and indirect comparisons across trials based on a common comparator \[[@CR10]--[@CR14]\]. Thus, we performed a systematic review and network meta-analysis based on published relevant studies to evaluate the feasibility and safety of each PCNL procedure, including total tubeless, tubeless with stent, small-bore tube, and large-bore tube PCNLs, for the treatment of renal stones.

Methods {#Sec2}
=======

Inclusion and exclusion criteria {#Sec3}
--------------------------------

Reported RCTs that fitted the following criteria were selected: (i) a design of each study that involved comparing the feasibility and safety for least two PCNL procedures, including total tubeless, tubeless with stent, small-bore tube, and large-bore tube PCNLs; (ii) the study groups were matched for baseline characteristics, including the total number of subjects and the values of each variable; (iii) at least one of the following outcomes was assessed: operation time, hospital stay length, hemoglobin decrease, return to normal activity, and complication rate; and (iv) the full text of each study was accessible and written in English.

The exclusion criteria were as follows: (i) noncomparative studies; (ii) the trial included children; and (iii) the trial did not exclude patients who underwent bilateral simultaneous PCNL or had complete or partial staghorn stones, more than two nephrostomy tracts, anatomical anomalies, or urinary infection. This report was prepared in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (accessible at <http://www.prisma-statement.org/>) \[[@CR15]\].

Search strategy {#Sec4}
---------------

A literature search was performed to identify RCTS published prior to December 30, 2013 in PubMed, the Cochrane Central Register of Controlled Trials, and EMBASE™ online databases. A cross-reference search of eligible articles was performed to identify additional studies not found by the computerized search. Combinations of the following MeSH and key words were used: percutaneous nephrolithotomy or nephrostomy or percutaneous nephrostomy or nephrolithiasis or PCNL or PCN or PNL, and total tubeless or tubeless or nephrostomy free.

Data extraction {#Sec5}
---------------

One researcher (J.Y.L.) screened the title and abstract of all articles retrieved using the search strategy. The other two investigators (D.H.K. and H.L.) independently assessed the full text of the articles to determine whether they met the inclusion criteria. For each included study, the following data were extracted independently as follows; authors, date, demographics of included patients, PCNL methods, feasibility, efficacy outcomes, complications, and inclusion of a reference standard. Disagreements arising in the study selection and data extraction processes were resolved by discussion until a consensus was reached or by arbitration employing another researcher (K.S.C.).

Study quality assessment {#Sec6}
------------------------

Once the final group of articles was agreed upon, two researchers (J.Y.L. and D.H.K.) independently examined the quality of each article using the Cochrane's risk-of-bias as a quality assessment tool for RCTs. The assessment involves the assignment of a "yes," "no," or "unclear" rating for each domain, designating a low, high, or unclear risk of bias, respectively. If ≤1 domain was rated "unclear" or "no," the study was classified as having a low risk of bias. If ≥4 domains were rated "unclear" or "no," the study was classified as having a high risk of bias. If 2 or 3 domains were rated "unclear" or "no," the study was classified as having a moderate risk of bias. \[[@CR16]\]. Quality assessment was performed using Review Manager 5.2 (RevMan 5.2.11, Cochrane Collaboration, Oxford, UK).

Statistical analyses {#Sec7}
--------------------

Each outcome variable at specific time-points was compared by network meta-analysis using the odds ratio (OR) or mean difference (MD) with 95% confidence interval (CI). A random-effect model was used. Each analysis was based on non-informative priors for effect size and precision. Convergence and lack of auto-correlation were checked and confirmed after four chains and a 50,000-simulation burn-in phase, and direct probability statements were based on an additional 100,000-simulation phase. Calculation of the probability that each group had the lowest rate of clinical events was performed using Bayesian Markov Chain Monte Carlo modeling. Sensitivity analyses were performed by repeating the main computations using a fixed-effect method. Model fit was appraised by computing and comparing estimates for deviance and deviance information criterion. Pairwise inconsistency and inconsistency between direct and indirect effect estimates were assessed with the I^2^-statistic, with values \<25%, 25% to 50%, and \>50% representing mild, moderate, and severe inconsistency, respectively. The extent of small study effects/publication bias was assessed by visual inspection of funnel plots for the pairwise meta-analyses. All statistical analyses were performed using Review Manager 5 and R (R version 3.0.3, R Foundation for Statistical Computing, Vienna, Austria; <http://www.r-project.org>) \[[@CR17]\], and its meta, forestplot, gemtc, and R2WinBUGS packages for pairwise and network meta-analyses using Bayesian Markov Chain Monte Carlo modeling.

Results {#Sec8}
=======

Eligible studies {#Sec9}
----------------

Our database search identified 43 studies that could be potentially included in the meta-analysis. Based on the inclusion and exclusion criteria, 18 articles were excluded during screening of the titles and abstracts because they were retrospective studies (11 articles) or case series (7 articles). This left 25 RCTS that evaluated various types of PCNL procedures for renal stones. After reviewing the full-text articles for these studies, 9 were excluded because they reported irrelevant results. Therefore, 16 RCTs were ultimately included in the qualitative analysis, as well as the quantitative synthesis using pairwise and network meta-analyses (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Search strategy for a systematic review and meta-analysis to compare the feasibility and safety of different PCNL procedures, including total tubeless, tubeless with stent, small-bore tube, and large-bore tube PCNLs

There were differences in procedures among the included studies. Five studies included comparisons between standard and total tubeless PCNLs, and five RCTs also compared standard and tubeless PCNLs. Four trials reported on various factors in small-bore and tubeless PCNLs. In two studies, the results of three arms---standard, small-bore, and tubeless PCNLs---were published (Table [1](#Tab1){ref-type="table"}). Finally, the included studies covered four different PCNL procedures: total tubeless, tubeless, standard and small-bore PCNLs (Fig. [2](#Fig2){ref-type="fig"}).Table 1Characteristics of included trialsStudyYearDesignProceduresSample sizeAge (year)Stone burdenTubeStone-free rateQuality assessmentSize*P*-value(%)*P*-valueChang et al. \[[@CR41]\].2011RCTStandard6358.724.86 ± 2.78 mm0.72220 Fr (7 Fr)75%0.51LowTotal tubeless6859.224.74 ± 2.69 mmNone74%Aghamir et al. \[[@CR42]\].2011RCTStandard35402.87 ± 0.62 cm^2^0.66NA83%NALowTotal tubeless3538.42.81 ± 0.59 cm^2^None86%Kara et al. \[[@CR43]\].2010RCTStandard3066.525.6 mmNA18 Fr90%\>0.05LowTotal tubeless3067.722.3 mmNone96%Mishra et al. \[[@CR44]\].2010RCTStandard1142.52737 μL0.1820 Fr81.8%0.14LowTubeless1142.32934.2 μLNone (6 Fr)72.7%Istanbulluoglu et al. \[[@CR45]\].2009RCTStandard4543.9432.35 ± 195.97 mm^2^0.4614 FrNANALowTotal tubeless4547.5448.93 ± 249.13 mm^2^NoneNACrook et al. \[[@CR46]\].2008RCTStandard255317.5 mmNA26 Fr84%NALowTotal tubeless255221.6 mmNone96%Agrawal et al. \[[@CR47]\].2008RCTStandard10131NANA16 Fr100%--LowTubeless10133NANone (6 Fr)100%Singh et al. \[[@CR48]\].2008RCTStandard3034800 mm^2^\>0.0522 Fr93.3%0.64ModerateTubeless3031750 mm^2^None (NA)90%Shah et al. \[[@CR18]\].2008RCTSmall-bore tube3246.7495.92 mm^2^0.888Fr87.5%0.96LowTubeless3344.1535.36 mm^2^None (6 Fr)87.9%Sofikerim et al. \[[@CR35]\].2007RCTStandard2454.1425 mm^2^NA24 Fr or 18 Fr85% (24 Fr),0.71ModerateTubeless2447.8428 mm^2^None (6 Fr)83% (18 Fr), 79%Tefekli et al. \[[@CR49]\].2007RCTStandard1841.323.1 cmNA14 Fr89%\>0.05ModerateTubeless1738.42.8 cmNone (NA)94%Weiland et al. \[[@CR50]\].2007RCTSmall-bore tube9656.7 cm^2^0.158.3 FrModerateTubeless9543.2 cm^2^None (8.2 Fr)Choi et al. \[[@CR32]\].2006RCTSmall-bore tube124732.41 mm0.778.2 Fr91.7%0.64HighTubeless1252.928.5 mmNone (6 Fr)100%Desai et al. \[[@CR51]\].2004RCTStandard1043.4263.7 mm^2^\>0.0520 Fr100%--ModerateSmall-bore tube1044.8243 mm^2^9 Fr100%Tubeless1041.1249.1 mm^2^None (6 Fr)100%Marcovich et al. \[[@CR52]\].2004RCTStandard20583.6 cm0.6424 Fr0.63ModerateSmall-bore tube20613 cm8 FrTubeless20573.4 cmNone (NA)Feng et al. \[[@CR53]\].2001RCTStandard10538.4 cm^3^0.7522 Fr31.5%NAModerateTubeless8624.4 cm^3^None (NA)71.4%*NA* not applicable, *RCT* randomized controlled trial Fig. 2Comparison network of included randomized controlled trials. Five studies included comparisons between standard and total tubeless PCNLs, and five RCTs also compared standard and tubeless PCNLs. Four trials reported on various factors in small-bore and tubeless PCNLs. In two studies, the results of three arms---standard, small-bore, and tubeless PCNLs---were published

Quality assessment and publication bias {#Sec10}
---------------------------------------

Figures [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} present the details of quality assessment, as measured by the Cochrane Collaboration risk-of-bias tool. Seven trials exhibited a moderate risk of bias for all quality criteria and only one study was classified as having a high risk of bias (Table [1](#Tab1){ref-type="table"}). For operation time, hemoglobin change, and transfusion rate, little evidence of publication bias was demonstrated on funnel plots; however, for the visual analogue scale (VAS) pain score and hospital stay, moderate evidence of publication bias was demonstrated on these plots (Fig. [5](#Fig5){ref-type="fig"}).Fig. 3Risk-of-bias summary: review of the authors' judgments on each risk-of-bias item for each included study Fig. 4Risk-of-bias graph: review of the authors' judgments on each risk-of-bias item presented as percentages across all included studies Fig. 5Funnel plots of each variable. **a** Operation time, **b** visual analogue scale (VAS) pain score, **c** hemoglobin change, **d** length of stay, and **e** transfusion rate. For operation time, hemoglobin change, and transfusion rate, little evidence of publication bias was demonstrated on visual or statistical examination of the funnel plots; however, for VAS scores and hospital stay, moderate evidence of publication bias was demonstrated on visual or statistical examination of the plots

Operation time {#Sec11}
--------------

During the pairwise meta-analysis of operation time between standard and total tubeless PCNLs, there was a significant degree of heterogeneity among these studies, and data were pooled with a random effects model (*P* = 0.04, I^2^ = 69%). There was no statistically significant difference in operation time between standard and total tubeless PCNLs, although the MD was 6.19 (95% CI -0.14 to 12.52) (Fig. [6a](#Fig6){ref-type="fig"}). Between standard and tubeless PCNLs with stent, the MD also demonstrated no statistical difference (MD 7.43, 95% CI -1.70 to 16.57) (Fig. [6b](#Fig6){ref-type="fig"}). Likewise, the MDs did not exhibit statistically significant differences for standard versus small-bore PCNLs (MD -1.0, 95% CI -11.93 to 9.93) or tubeless versus small-bore PCNLs (MD 0.86, 95% CI -7.95 to 9.68) (Fig. [6c](#Fig6){ref-type="fig"}). Using network meta-analysis, there were no significant differences among all procedures (Fig. [7a](#Fig7){ref-type="fig"}) (Table [2](#Tab2){ref-type="table"}), although total tubeless and small-bore PCNLs had higher rank probabilities than the other procedures (Fig. [8a](#Fig8){ref-type="fig"}).Fig. 6Forest plots for operation time using pairwise meta-analysis. **a** Standard versus total tubeless PCNLs, **b** standard versus tubeless PCNLs, and **c** tubeless versus small-bore PCNLs. SD, standard deviation; MD, Mean difference; CI, confidence interval; W, Weight Fig. 7Forest plots for (**a**) operation time, **b** visual analogue scale, **c** hemoglobin change, **d** hospital stay, and **e** transfusion rate using network meta-analysis Table 2Results of network and pairwise meta-analyses comparing procedures for operation time, visual analogue scale pain score, hemoglobin change, and hospital stayProceduresNetwork meta-analysisPairwise meta-analysisMean difference95% CIMean difference95% CIOperation time Standard  Total tubeless6.11−3.14 -- 17.026.19^a^−0.14 -- 12.52  Tubeless6.28−2.71 -- 17.067.43^a^−1.70 -- 16.57  Small-bore tube7.09−6.03 -- 20.95NA Total tubeless  Tubeless0.08−13.60 -- 14.27NA  Small-bore tube0.95−16.46 -- 17.52NA Tubeless  Small-bore tube0.80−14.27 -- 13.600.86^b^−7.95 -- 9.68Visual analogue scale pain score Standard  Total tubeless1.25−2.80 -- 5.22NA  Tubeless1.20−0.75 -- 3.140.06^a^−0.56 -- 0.69  Small-bore tube2.00−1.03 -- 5.14NA Total tubeless  Tubeless−0.07−4.58 -- 4.41NA  Small-bore tube0.75−4.37 -- 5.89NA Tubeless  Small-bore tube0.80−1.51 -- 3.241.21^a^−0.02 -- 2.44Hemoglobin change Standard  Total tubeless0.650.14 -- 1.130.23^a^−0.12 -- 0.58  Tubeless−0.48−0.87 -- −0.09-0.29^a^−0.53 -- −0.05  Small-bore tube0.73−0.21 -- 1.60NA Total tubeless  Tubeless−1.14−1.65 -- −0.62NA  Small-bore tube0.06−0.76 -- 0.92NATubeless  Small-bore tube1.300.27 -- 2.26−0.02^a^−1.13 -- 1.10Hospital stay Standard  Total tubeless1.330.23 -- 2.431.42^b^1.10 -- 1.75  Tubeless0.990.19 -- 1.790.54^a^−1.03 -- 2.11  Small-bore tube0.73−0.57 -- 1.98NA Total tubeless  Tubeless−0.33−1.71 -- 1.04NA  Small-bore tube−0.60−2.29 -- 1.08NA Tubeless  Small-bore tube−0.28−1.39 -- 0.830.06^a^−0.56 -- 0.69*CI* confidence interval, *NA* not applicable^a^Random-effect model with inverse variance method^b^Fixed-effect model with inverse variance method Fig. 8Rank probability test. **a** Operation time, **b** visual analogue scale, **c** hemoglobin change, **d** hospital stay, and **e** transfusion rate

Visual analogue scale pain score {#Sec12}
--------------------------------

In the pairwise meta-analysis of VAS pain scores, there was a significant degree of heterogeneity among studies and the data were pooled with a random effects model. There were no statistically significant differences comparing standard versus total tubeless PCNLs with stent (MD 0.06, 95% CI -0.56 to 0.69, *P* = 0.84) (Fig. [9a](#Fig9){ref-type="fig"}) or tubeless versus small-bore PCNLs (MD 1.21, 95% CI -0.02 to 2.44, *P* = 0.05) (Fig. [9b](#Fig9){ref-type="fig"}). In the network meta-analysis, there were no statistically significant differences among all procedures for VAS pain scores (Fig. [7b](#Fig7){ref-type="fig"}) (Table [2](#Tab2){ref-type="table"}), although the rank probabilities demonstrated that small-bore and total tubeless PCNLs may be superior to the other procedures (Fig. [8b](#Fig8){ref-type="fig"}).Fig. 9Forest plots for visual analogue scale pain score using pairwise meta-analysis. **a** Standard versus total tubeless PCNLs, and **b** standard versus tubeless PCNLs, SD, standard deviation; MD, Mean difference; CI, confidence interval; W, Weight

Hemoglobin change {#Sec13}
-----------------

Using pairwise meta-analysis for hemoglobin change, three comparisons, including standard versus total tubeless PCNLs, standard versus tubeless PCNLs with stent, and tubeless versus small-bore PCNLs, were examined (Fig. [10](#Fig10){ref-type="fig"}). Only one comparison for standard versus tubeless PCNLs with stent showed a statistically significant difference (MD -0.29, 95% CI -0.53 to −0.05, *P* = 0.02) (Fig. [10b](#Fig10){ref-type="fig"}). Network meta-analysis demonstrated that total tubeless PCNL may be superior to standard PCNL (MD 0.65, 95% CI 0.14 to 1.13). Total tubeless (MD -1.14, 95% CI -1.65 to −0.62), and small-bore PCNLs (MD 1.30, 95% CI 0.27 to 2.26) were also superior to tubeless PCNL with stent for hemoglobin change (Fig. [7c](#Fig7){ref-type="fig"}) (Table [2](#Tab2){ref-type="table"}). In rank probabilities, total tubeless and small-bore PCNLs were ranked higher than the other procedures (Fig. [8c](#Fig8){ref-type="fig"}).Fig. 10Forest plots for hemoglobin change using pairwise meta-analysis. **a** Standard versus total tubeless PCNLs, **b** standard versus tubeless PCNLs, and **c** tubeless versus small-bore PCNLs. SD, standard deviation; MD, Mean difference; CI, confidence interval; W, Weight

Hospital stay {#Sec14}
-------------

The length of hospital stay in patients who underwent total tubeless PCNL was shorter than for those who underwent standard PCNL (MD 1.42, 95% CI 1.10 to 1.75, *P* \< 0.01) during pairwise meta-analysis (Fig. [11](#Fig11){ref-type="fig"}). Network meta-analysis also demonstrated that total tubeless (MD 1.33, 95% CI 0.23 to 2.43) and tubeless PCNLs with stent (MD 0.99, 95% CI 0.19 to 1.79) may be superior to standard PCNL, producing a shorter hospital stay (Fig. [7d](#Fig7){ref-type="fig"}). However, there was no significant difference between total tubeless and tubeless PCNLs with stent (MD -0.33, 95% CI -1.71 to 1.04) (Table [2](#Tab2){ref-type="table"}), although total tubeless PCNL showed the highest rank probability of all procedures (Fig. [8d](#Fig8){ref-type="fig"}).Fig. 11Forest plots for hospital stay using pairwise meta-analysis. **a** Standard versus total tubeless PCNLs, **b** standard versus tubeless PCNLs, and **c** tubeless versus small-bore PCNLs. SD, standard deviation; MD, Mean difference; CI, confidence interval; W, Weight

Transfusion rate {#Sec15}
----------------

The transfusion rate did not exhibit significant differences between any of the procedures during both pairwise analysis (Fig. [12](#Fig12){ref-type="fig"}) and network meta-analysis (Fig. [7e](#Fig7){ref-type="fig"}) (Table [3](#Tab3){ref-type="table"}). Rank probabilities demonstrated that small-bore and tubeless PCNLs with stent may be superior to the other procedures (Fig. [8e](#Fig8){ref-type="fig"}).Fig. 12Forest plots for transfusion rate using pairwise meta-analysis. **a** Standard versus total tubeless PCNLs, **b** standard versus tubeless PCNLs, and **c** tubeless versus small-bore PCNLs. OR, Odds ratio; CI, confidence interval; W, Weight Table 3Results of network and pairwise meta-analyses comparing procedures for transfusion rateProceduresNetwork meta-analysisPairwise meta-analysis^a^OR95% CIOR95% CIStandard Total tubeless1.270.35--4.401.170.41--3.30 Tubeless2.940.73--14.063.790.75--19.20 Small-bore tube2.760.46--24.52NATotal tubeless Tubeless2.370.34--18.19NA Small-bore tube2.390.24--22.21NATubeless Small-bore tube1.000.19--5.301.230.34--4.53*CI* confidence interval, *OR* odds ratio^a^Fixed-effect model with Mantel-Haenszel method

Discussion {#Sec16}
==========

Conventionally, the placement of a nephrostomy tube after PCNL was considered a necessary safety option. However, the use of a nephrostomy tube has been associated with a prolonged hospital stay and more postoperative pain \[[@CR18]\]. In 1997, Bellman et al. first reported the use of tubeless PCNL using a double-J ureteral stent and Council catheter \[[@CR19]\]. They demonstrated that hospital length of stay, analgesia requirements, time to return to normal activities, and cost were significantly less with this procedure. Although the procedure gained popularity, tubeless PCNL with stent had two important problems: ureteral stent discomfort and loss of the advantages of a nephrostomy tube. Thus, some urologists used the approach of placing the smallest possible nephrostomy tube to minimize patient discomfort while maintaining access to the renal collecting system \[[@CR20]\]. With the recent development of a high-density telescope, high-quality lithotripters, and radiological interventional techniques to embolize blood vessels, several investigators reported that tubeless and total tubeless (stentless) PCNL in selected patients was safe and associated with a reduced hospital length of stay and analgesic requirements.

The results of RCTs for each PCNL procedure have been reported, and previous systematic reviews and meta-analyses have been published. However, most of the studies reported in the previous meta-analyses compared standard PCNL versus tubeless PCNL with stent or standard PCNL versus total tubeless PCNL \[[@CR21]--[@CR25]\]. Therefore, an integrated analysis of standard, small-bore tube, tubeless with stent, and total tubeless PCNLs has not yet been published.

In our study, using network meta-analysis, there were no significant differences in operation time for the four procedures. It is known that large stones increase operation time and complication rates \[[@CR26], [@CR27]\], and operation times vary depending on the size and characteristics of the stone.

We also detected no statistically significant differences between methods for the VAS pain scores. No significant differences were observed between standard versus total tubeless PCNLs and tubeless versus small-bore tube PCNLs not only during the network meta-analysis, but even during pairwise meta-analyses. Operation-related factors that may prolong pain after PCNL include the nephrostomy tube size \[[@CR28]\] and stent discomfort caused by a double-J stent \[[@CR29]\], but statistically significant differences between procedures were not observed. This finding is presumably due to the relatively small sample size (only eight studies reported the VAS pain scores), and the possibility of publication bias, as suggested by the asymmetric funnel plot (Fig. [5b](#Fig5){ref-type="fig"}). However, in the rank probability test of pain scores using Bayesian Markov Chain Monte Carlo modeling, small-bore tube PCNL was ranked highest, followed by the total tubeless PCNL and then tubeless PCNL with stent (Fig. [8b](#Fig8){ref-type="fig"}). Additional RCTs are necessary in the future to more definitively address this issue.

With regard to the hemoglobin changes, network meta-analysis showed that total tubeless and small-bore tube PCNLs were superior, and tubeless with stent PCNL was the worst. In addition, total tubeless and small-bore PCNLs showed similar superiority in the network meta-analysis and rank probability test (Fig. [8c](#Fig8){ref-type="fig"}). Considering that all enrolled studies were RCTs, the possibility of selection bias between patients who had total tubeless or small-bore tube PCNLs and other procedures should be relatively low. For tubeless PCNLs, the possibility of bleeding caused by ureteral stenting should be considered. In previous studies, hematuria accounted for 13.6% of early complications and 18.1% of late complications after tubeless PCNL with stent \[[@CR29]\]. In contrast to the hemoglobin changes, transfusion rates were not different between the four procedures. This lack of difference is likely due to the development of high-quality surgical skills and patient monitoring approaches because of the popularity of PCNL procedures.

For the length of hospital stay, the total tubeless and tubeless PCNLs showed superiority. We assumed that this is because these methods do not require additional procedures, such as nephrostomy tube removal or tract revision.

During the rank probability for each variable, small-bore and tubeless PCNLs were ranked higher for operation time, VAS pain scores, and hemoglobin change. In addition, total tubeless PCNL was ranked highest for hospital stay and transfusion rate. Notably, total tubeless PCNL was ranked highest for each item. However, total tubeless PCNL has not been in widespread use, even considering the potential benefits of this approach, because of concerns that potentially fatal complications, such as massive bleeding without a nephrostomy tube in place, may occur \[[@CR30]\]. Because omitting a nephrostomy catheter may potentially increase the risk of bleeding and serious complications, various methods have been used in an attempt to seal the tract. Milkahi and colleagues were the first to describe the instillation of the hemostatic agent Tiseel® into the nephrostomy tract \[[@CR31]\]. However, they were unable to determine whether this diminished postoperative bleeding or urinary extravasation following tubeless PCNL. Choi et al. instilled gel matrix thrombin (Floseal®) into the tract whenever persistent bleeding was observed after omitting the nephrostomy catheter \[[@CR32]\]. Okeke et al. explored cryoablation of the nephrostomy tract after tubeless PCNL, where they inserted a cryoprobe into the access tract and performed a 10-min freeze-thaw cycle at a temperature -20 °C. This method did not significantly affect the rate of delayed bleeding or urinary extravasation \[[@CR33]\]. Recently, a randomized study by Cormio et al. showed that TachoSil® provided better tract control and a shorter hospital stay than nephrostomy tube placement, although it did not reduce pain or analgesic requirements \[[@CR34]\].

Total tubeless PCNL is advocated by leading surgeons in the field of endourology. The future role of tubed PCNL will likely reside primarily in cases of severe intraoperative bleeding or major damage to the collecting system, and when there is the possibility of a second-look operation. However, some controversies remain about the feasibility and efficacy of tubeless PCNLs in certain clinical settings. In their prospective randomized study, Shoma et al. suggested that the tubeless approach might not be suitable for patients with chronic kidney disease or those who require a supracostal approach \[[@CR30]\]. However, Shah et al. reported the successful use of a tubeless technique in a patient with chronic kidney disease. Likewise, Sofikerim et al. reported that tubeless PCNL is a safe and effective technique, even for supracostal access, and is associated with less postoperative pain and shorter hospital stay \[[@CR35]\]. Resorlu et al. maintained that single or no nephrostomy drainage following multitract PCNL offered the potential advantages of decreased postoperative analgesic requirements and shorter hospital stay, without increasing the rate of complications \[[@CR36]\].

A limitation of our study was that we did not perform subgroup analyses based on the size of the stone. We also did not compare success rates because the success rates were high in each study. In addition, there was some degree of publication bias. However, in the review of 48 articles from the Cochrane Database of Systematic Reviews performed by Sutton et al., publication or related biases were noted to be common within the sample of assessed meta-analyses, but did not affect the conclusions in most cases \[[@CR37]\]. Additionally, the position of the patient during PCNL (prone or supine position) can influence the outcomes of a tubeless or not tubeless procedure. Anesthesiologists prefer the supine position because of better airway control during procedures. Another advantage of the supine position is that there is no need for position changes when performing additional endoscopic procedures, such as cystoscopic or ureteroscopic operations \[[@CR38]\]. Endoscopic combined intrarenal surgery is also a novel way of performing PCNL in the supine position \[[@CR39]\]. Better visualization with the procedure allows for correct puncture of the kidney, and thus, can improve the safety and feasibility of a tubeless or total tubeless procedure.

Despite these limitations and shortcomings, our study has the substantial advantage of including larger samples from each study than the previously conducted pairwise meta-analyses \[[@CR40]\]. Moreover, this is the first study to use network meta-analysis to compare PCNL methods, which enhances the statistical confidence and overcomes the limitations of pairwise meta-analyses.

Conclusions {#Sec17}
===========

In comparing each procedure through network meta-analysis, total tubeless and small-bore PCNLs were superior in terms of hemoglobin change, and total tubeless and tubeless PCNLs were superior with regard to the length of hospital stay. These findings indicate that conventional PCNL can be replaced with other techniques, especially total tubeless PCNL, in selected patients.

PCNL

:   Percutaneous nephrolithotomy

RCT

:   Randomized controlled trial

VAS

:   Visual analogue scale
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